about
A systematic review of intervention thresholds based on FRAX : A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation.Osteoporosis imaging: state of the art and advanced imaging.Update in male osteoporosis.Prediction of absolute risk of fragility fracture at 10 years in a Spanish population: validation of the WHO FRAX ™ tool in Spain.Epidemiology of hip fracture and the development of FRAX in Ukraine.Application of the National Osteoporosis Foundation Guidelines to postmenopausal women and men: the Framingham Osteoporosis StudyClinician's Guide to Prevention and Treatment of OsteoporosisA knowledge translation tool improved osteoporosis disease management in primary care: an interrupted time series analysis.FRAX® tool, the WHO algorithm to predict osteoporotic fractures: the first analysis of its discriminative and predictive ability in the Spanish FRIDEX cohort.Bone quality: educational tools for patients, physicians, and educators.Osteoporosis in men: a review.Rationale of the Spanish FRAX model in decision-making for predicting osteoporotic fractures: an update of FRIDEX cohort of Spanish womenOsteoporosis in men: insights for the clinicianBreast Density and Benign Breast Disease: Risk Assessment to Identify Women at High Risk of Breast Cancer.Potential Extensions of the US FRAX Algorithm.Male osteoporosis: A reviewHeight loss predicts subsequent hip fracture in men and women of the Framingham Study.Trends in fracture incidence: a population-based study over 20 years.Osteoporosis in men: what has changed?Glucocorticoid-induced osteoporosis in men.Interpretation and use of FRAX in clinical practice.Osteoporosis in men: recent progress.Effects of Long-Term Low-Molecular-Weight Heparin on Fractures and Bone Density in Non-Pregnant Adults: A Systematic Review With Meta-Analysis.Epidemiology of fracture in the Russian Federation and the development of a FRAX model.Clinical characteristics and incidence of first fracture in a consecutive sample of post-menopausal women attending osteoporosis centers: The PROTEO-1 study.Hip fracture risk in older US adults by treatment eligibility status based on new National Osteoporosis Foundation guidance.Major osteoporotic to hip fracture ratios in canadian men and women with Swedish comparisons: a population-based analysis.Effect of alendronate for reducing fracture by FRAX score and femoral neck bone mineral density: the Fracture Intervention Trial.Regional and age-related variations in the proportions of hip fractures and major fractures among postmenopausal women: the Global Longitudinal Study of Osteoporosis in Women.Evaluation of the FRAX model for hip fracture predictions in the population-based Kuopio Osteoporosis Risk Factor and Prevention Study (OSTPRE).Early postmenopausal bone loss and what to do about it.The potential impact of the National Osteoporosis Foundation guidance on treatment eligibility in the USA: an update in NHANES 2005-2008.Epidemiology of fractures in Armenia: development of a country-specific FRAX model and comparison to its surrogate.Secondary fracture prevention.Evaluation of FRAX to characterise fracture risk in Poland.Epidemiology of hip fracture in Belarus: development of a country-specific FRAX model and its comparison to neighboring country models.Construction of a FRAX® model for the assessment of fracture probability in Canada and implications for treatmentIndependent clinical validation of a Canadian FRAX tool: Fracture prediction and model calibration
P2860
Q30248756-C0014095-3AA2-46C6-B1EA-B12135D73E67Q30455960-695F4759-B47F-4338-92C2-D709711FF322Q33586703-B1DFEA6C-FC5C-4C89-9C74-8193405E23E8Q33805608-5195111C-64CE-4642-AE9E-A16DB31818E0Q33841213-2AFF72B6-BAA7-4016-BCF5-C08861F9C676Q33929951-207B967C-AAE3-4B52-B390-7E25559580FDQ34250632-D9C6BC5C-C2D2-48A4-8992-4F11D8CAEE3EQ34278513-456753C3-D5EE-4702-80DF-D7692E18E239Q34454001-EBA73C28-6DCB-48A4-AEC4-E7ADAD2C84E7Q35078751-37A02F94-B3B5-4F8F-ACCD-D0D7DF0587B6Q35755160-7538701E-ACFF-4EAD-BB42-1B52EBE38F3CQ36056006-81F15863-B7E3-4A0A-8F38-50E38EFD0725Q36056965-BFA24E9A-6452-4316-BDB0-D6ABE84703CBQ36090967-BDAA4CB8-43FA-46DB-8D41-27B2E48CE90AQ36184831-9AD22E29-34C6-4256-A5D3-E64F88F558A1Q36568540-D194E942-7721-496C-BD1D-C98310479618Q36826083-DEDC16CC-46E6-468A-976D-C0EE1B658AFFQ37593831-A3AC0EBA-2AEF-4CA0-A0D9-824FD5444D5DQ37813046-EAA563CF-DFD9-4083-B8AA-5B70578CC86AQ37881839-9770CAD2-D0C5-4D8A-B235-CD07E606653EQ37903748-93F9DCED-88B1-49A7-8836-74D46C62D57EQ38077109-7C9ED633-D97A-4F6C-BDF2-CF1460C90983Q38741507-7540CA4D-322A-4DEB-B5A5-9C1DF61A9A73Q39506150-7386C806-8B00-4FF4-85A6-A132AC8873BBQ39710159-0A91CFFC-477A-413C-8655-2768FA2B9608Q39872287-AE6FCB29-20FB-4B03-BCAF-0BB3BA3E6B44Q43499727-977710A9-0ACB-474D-BF8D-7342A137BA78Q44063452-26E2F242-2C71-4A4C-A1BC-8D737E0D2B40Q45000136-930AA835-A547-42C7-BBE5-2E15F5028960Q45343378-8B8C4483-79A8-4409-AC43-F920D4EA24BEQ46485057-35C4991D-D176-40F5-98D5-CE307A175E37Q46795256-30D0BF49-18C6-4BB7-B6CF-535AE9810236Q47094212-B07DB573-062F-43D0-9515-99D6575FC5BAQ48737464-1153B92A-AE47-4BCE-8A77-2500E4641973Q51628299-A4DC0F17-FB24-499A-9AF4-0F760211FFFDQ55317088-23FE4CAE-241E-4618-A0C2-0B652953332BQ57711656-415A6623-C5C7-42D9-BE4D-7F69EE206234Q57711695-6B9DA6EE-A2FC-4E92-ACDC-E12AEE8F122A
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
The effects of a FRAX revision for the USA.
@en
The effects of a FRAX revision for the USA.
@nl
type
label
The effects of a FRAX revision for the USA.
@en
The effects of a FRAX revision for the USA.
@nl
prefLabel
The effects of a FRAX revision for the USA.
@en
The effects of a FRAX revision for the USA.
@nl
P2093
P1476
The effects of a FRAX revision for the USA.
@en
P2093
B Dawson-Hughes
E V McCloskey
H Johansson
L J Melton
P2888
P356
10.1007/S00198-009-1033-8
P407
P577
2009-08-25T00:00:00Z